News and announcements
Find out the important news about us, meetings, and the companies we invest in.
Infratil Newsletter – April 2025 (CDC site visit)
CDC Well Positioned for Growth, Driven by AI and Hyperscale Demand Last Wednesday (9 April 2025), CDC CEO Greg Boorer and members of his senior management team hosted an investor
Ongoing Disclosure Notices - Directors and Senior Manager
Ongoing disclosure notices attached for Alison Gerry, Jason Boyes, Anne Urlwin and Paul Newfield
CDC hosts Melbourne data centre site visit
CDC management hosted a briefing today as part of a site visit to its new Brooklyn campus in Melbourne, which became operational in 2024. A copy of the presentation from
CDC Independent Valuation – 31 March 2025
As a result of the transaction announcement in February, the primary valuation methodology applied by the independent valuer at 31 March 2025 was adjusted from a Discounted Cash Flow (‘DCF’)
Infratil Newsletter – March 2025
The first quarter of the new calendar year has been marked by uncertainty and volatility across global markets. In recent weeks, equity markets have experienced heightened fluctuations, driven by escalating
Infratil Independent Valuation Update - 31 December 2024
Infratil Limited's 31 December 2024 independent valuation update is attached. As noted in the attached, a number of Infratil's investments have independent valuations completed as at 31 December, with those
Infratil Increases its Investment in CDC
Infratil Limited (“Infratil”) (NZX/ASX: IFT) today announces that, alongside The Future Fund (“Future Fund”), it has exercised pre-emption rights to acquire a 12.04% stake in CDC Data Centres (“CDC”) from